Furthermore, the four validated mirT RDDs in DDX58 and CCNYL1 resided in binding regions of miRNAs hsa-miR-10b, hsa-miR-98 and hsa-miR-122, which have all been reported to be dysregulated in prostate cancer relative to adjacent benign[43]. Here, RIGI is linked to prostate cancer.